Results 21 to 30 of about 1,959,681 (261)

Immunomodulation with Intrathymic Grafts or Anti-Lymphocyte Serum Promotes Long-Term Intraspinal Allograft Survival

Cell Transplantation, 1996
In this study, we sought to test whether introduction of fetal cells into the adult rat thymus would promote immunotolerance to subsequent donor-type allografts in the injured spinal cord.
Daniel P. Theele, Paul J. Reier Ph.D.
doaj   +1 more source

Hepatotoxicity induced by horse ATG and reversed by rabbit ATG: a case report

Journal of Medical Case Reports, 2007
Background The use of antilymphocyte agents has improved patient and graft survival in hematopoietic stem cell and solid organ transplantation but has been associated with the development of short-term toxicities as well as long-term complications.
Al-Anazi Khalid A, Aljurf Mahmoud D, Al-Sharif Fahad Z, Al-Omar Hamad M, Alami Ahmed, Farooq Fayyaz   +5 more
doaj   +1 more source

Heart Allograft Tolerance Induced and Maintained by Vascularized Hind-Limb Transplant in Rats

Clinical and Developmental Immunology, 2013
Organ/tissue transplantation has become an effective therapy for end-stage diseases. However, immunosuppression after transplantation may cause severe side effects. Donor-specific transplant tolerance was proposed to solve this problem. In this study, we
Quan Liu, Yong Wang, Atsunori Nakao, Wensheng Zhang, Vijay Gorantla, Xin Xiao Zheng   +5 more
doaj   +1 more source

Effects of natural thymocytotoxic autoantibody of NZB mice and of specifically prepared antilymphocyte serum on the tissue distribution of 51 Cr-labeled lymphocytes.

Journal of Immunology, 1973
This study deals with the effect of natural thymocytotoxic autoantibody (NTA) of NZB mouse serum and of specifically prepared antilymphocyte serum upon the tissue distribution of 51Cr-labeled mouse lymph node cells in syngeneic recipients.
T. Shirai, T. Yoshiki, R. Mellors
semanticscholar   +1 more source

Successful Single Donor Islet Allotransplantation in the Streptozotocin Diabetes Rat Model

Cell Transplantation, 2002
The objective of this study was to define pretransplant islet culture conditions for optimum tissue engraftment in the rat islet allotransplantation model. Lewis rat islets were cultured in TCM 199/5% fetal calf serum for 1 day at 37°C, followed by 1 day
Henning Jahr, Birte Hußmann, Torsten Eckhardt, Reinhard G. Bretzel   +3 more
doaj   +1 more source

Thoracic duct fistula and renal transplantation [PDF]

, 1979
Thoracic duct drainage (TDD) was established for 21-115 days in 40 kidney recipients with an average removal per patient day of 4.7 1 lymph and 1.88 billion cells. Cellular and humoral immunity were depressed. TDD and immunosuppressive drugs were started
Franks, JJ, Halgrimson, CG, Iwaki, Y, Koep, LJ, McCalmon, RT, Schröter, GP, Starzl, TE, Subryan, V, Terasaki, PI, Weil, R   +9 more
core   +2 more sources

Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

Клиническая онкогематология, 2019
Background & Aims. Paroxysmal nocturnal hemoglobinuria (PNH) is a disease caused by an acquired clonal disorder of hematopoietic stem cells with clone cell membrane hypersensitivity to the complement.
Elena Romanovna Shilova, T. V. Glazanova, Zh. V. Chubukina, O. E. Rozanova, M. N. Zenina, A. V. Seltser, V. I. Rugal, V. A. Balashova, V. A. Kobilyanskaya, I. I. Krobinets, V. Yu. Udal’eva, I. I. Zotova, L. V. Stelmashenko, N. A. Romanenko, T. B. Zamotina, I. V. Khorsheva, S. V. Voloshin   +16 more
doaj   +1 more source

Effect of preoperative thoracic duct drainage on canine kidney transplantation [PDF]

, 1996
Chronic drainage of the thoracic duct to the esophagus was developed in dogs, and its efficacy in immunomodulation was tested using kidney transplantation. Compared to 9.7 days in the control, the mean animal survival was prolonged to 9.9 days, 17.8 days,
Archimbaud JP, Atsuhito Yagihashi, Depster WJ, Dumont AE, Fischer DC, Franksson C, Franksson C, Giuseppe Carrieri, Gowans JL, Harvey J, Janossy G, Johnson HK, Julius MH, Kawai T, Koep LJ, Kohler G, Krawiec DR, Lemke H, Machieder HI, McGregor DD, McKneally M, Medawar PB, Meeker W, Mukenzie JL, Murray JE, Mysliwietz JJ, Newton WT, Oh CY, Prendergast MM, Sales HE, Satoru Todo, Schwartz R, Shibata Y, Starzl TE, Starzl TE, Starzl TE, Thomas E. Starzl, Traeger J, Williamson E PM, Woodruff M FA, Wulff JC, Wulff JC, Yoichi Funakoshi, Yuichi Iwaki   +43 more
core   +1 more source

FK506 IN PEDIATRIC KIDNEY-TRANSPLANTATION - PRIMARY AND RESCUE EXPERIENCE [PDF]

, 1995
Between December 14, 1989, and December 17, 1993,43 patients undergoing kidney transplantation alone at the Children’s Hospital of Pittsburgh received FK506 as the primary immunosuppressive agent. The mean recipient age was 10.2 ± 4.8 years (range 0.7–17.
ELLIS, D, GILBOA, N, HAKALA, TR, HOPP, L, IRISH, W, JORDAN, ML, MCCAULEY, J, MITCHELL, S, SCANTLEBURY, VP, SHAPIRO, R, SIMMONS, RL, STARZL, TE, TZAKIS, AG, VIVAS, C   +13 more
core   +1 more source

Fk506 “rescue” for resistant rejection of renal allografts under primary cyclosporine immunosuppression [PDF]

, 1994
Seventy-seven patients with ongoing acute rejection on initial CsA therapy were converted to FK506 to attempt graft salvage. Fifty-nine patients had undergone primary transplantation and 18 had been retransplanted; there were 52 cadaveric and 25 living ...
Carrieri, G, Demetris, AJ, Fung, JJ, Hakala, TR, Jordan, ML, Mc Cauley, J, Rhandhawa, P, Scantlebury, VP, Shapiro, R, Simmons, RL, Starzl, TE, Tzakis, A, Vivas, CA   +12 more
core   +1 more source